FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4289133744> ?p ?o ?g. }

• W4289133744 endingPage "1375" @default.
• W4289133744 startingPage "1368" @default.
• W4289133744 abstract "Abstract Introduction Extracorporeal shock wave therapy is an established treatment for erectile dysfunction and Peyronie's disease. Concerns regarding the safety of extracorporeal shock wave therapy for andrological purposes on testicular function were raised by animal studies. Aim To evaluate the impact of extracorporeal shock wave therapy for erectile dysfunction or Peyronie's disease on reproductive and hormonal testicular function. Methods We designed a prospective controlled study in which consecutive patients were enrolled. Males aged between 18 and 40 years with mild vasculogenic erectile dysfunction or acute inflammatory Peyronie's disease and normozoospermia were included. All enrolled patients were offered extracorporeal shock wave therapy, and subjects who refused extracorporeal shock wave therapy for any reason were considered as the Control group. All patients in the Intervention group were treated with DUOLITH SD1 T‐TOP by a single expert urologist. Semen analysis and serum total testosterone dosage were performed before the start (T0) and 3 months after the end of extracorporeal shock wave therapy (T1) in Intervention group. The same parameters were evaluated after the extracorporeal shock wave therapy refusal (T0) and at the end of the following 3 months (T1) in Control group. Normozoospermia was chosen as the primary outcome, serum total testosterone concentration was selected as the secondary outcome. Results A total of 94 patients were enrolled in the study (48 Group A, 46 Group B). At T0, all patients were normozoospermic in both groups ( p = 0.563), and no significant difference in mean ± SD total testosterone levels was recorded between the groups (582.5 ± 107.2 vs. 634.6 ± 108.4 ng/dl; p = 0.221). At T1, no significant deterioration ( p > 0.05) in semen parameters was recorded in both groups. Only a statistically significant reduction in seminal pH was found after extracorporeal shock wave therapy compared to baseline (7.9 ± 0.3 vs. 7.5 ± 0.2; p < 0.001) and untreated patients (7.8 ± 0.2 vs. 7.5 ± 0.2; p < 0.001). No significant difference in total testosterone levels was recorded in Intervention group after extracorporeal shock wave therapy compared to baseline ( p = 0.584). Conclusion Extracorporeal shock wave therapy in erectile dysfunction and Peyronie's disease patients does not seem to affect reproductive and hormonal testicular function." @default.
• W4289133744 created "2022-08-01" @default.
• W4289133744 creator A5001087651 @default.
• W4289133744 creator A5014936380 @default.
• W4289133744 creator A5025735798 @default.
• W4289133744 creator A5037394901 @default.
• W4289133744 creator A5039731619 @default.
• W4289133744 creator A5044203595 @default.
• W4289133744 creator A5046658887 @default.
• W4289133744 creator A5051536719 @default.
• W4289133744 creator A5051787191 @default.
• W4289133744 creator A5055022840 @default.
• W4289133744 creator A5074579295 @default.
• W4289133744 creator A5076902141 @default.
• W4289133744 creator A5087530091 @default.
• W4289133744 date "2022-08-17" @default.
• W4289133744 modified "2023-10-05" @default.
• W4289133744 title "Impact of extracorporeal shockwave therapy for erectile dysfunction and Peyronie's disease on reproductive and hormonal testicular function" @default.
• W4289133744 cites W1669094501 @default.
• W4289133744 cites W1972273202 @default.
• W4289133744 cites W2026641917 @default.
• W4289133744 cites W2091256736 @default.
• W4289133744 cites W2105061671 @default.
• W4289133744 cites W2159706091 @default.
• W4289133744 cites W2162020807 @default.
• W4289133744 cites W2171236620 @default.
• W4289133744 cites W2270988457 @default.
• W4289133744 cites W2403922000 @default.
• W4289133744 cites W2557873308 @default.
• W4289133744 cites W2885130559 @default.
• W4289133744 cites W2897680886 @default.
• W4289133744 cites W2912901713 @default.
• W4289133744 cites W2913689246 @default.
• W4289133744 cites W2978462138 @default.
• W4289133744 cites W2988869110 @default.
• W4289133744 cites W2996296899 @default.
• W4289133744 cites W3003173007 @default.
• W4289133744 cites W3030781089 @default.
• W4289133744 cites W3081411703 @default.
• W4289133744 cites W3124506335 @default.
• W4289133744 cites W3126047966 @default.
• W4289133744 cites W3137812368 @default.
• W4289133744 cites W3157369185 @default.
• W4289133744 cites W3159298210 @default.
• W4289133744 cites W3164254195 @default.
• W4289133744 cites W3168870404 @default.
• W4289133744 cites W4210999425 @default.
• W4289133744 cites W4220719193 @default.
• W4289133744 cites W4220779563 @default.
• W4289133744 cites W4221037107 @default.
• W4289133744 cites W4289133744 @default.
• W4289133744 cites W62897906 @default.
• W4289133744 cites W891941391 @default.
• W4289133744 doi "https://doi.org/10.1111/andr.13240" @default.
• W4289133744 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35909300" @default.
• W4289133744 hasPublicationYear "2022" @default.
• W4289133744 type Work @default.
• W4289133744 citedByCount "7" @default.
• W4289133744 countsByYear W42891337442022 @default.
• W4289133744 countsByYear W42891337442023 @default.
• W4289133744 crossrefType "journal-article" @default.
• W4289133744 hasAuthorship W4289133744A5001087651 @default.
• W4289133744 hasAuthorship W4289133744A5014936380 @default.
• W4289133744 hasAuthorship W4289133744A5025735798 @default.
• W4289133744 hasAuthorship W4289133744A5037394901 @default.
• W4289133744 hasAuthorship W4289133744A5039731619 @default.
• W4289133744 hasAuthorship W4289133744A5044203595 @default.
• W4289133744 hasAuthorship W4289133744A5046658887 @default.
• W4289133744 hasAuthorship W4289133744A5051536719 @default.
• W4289133744 hasAuthorship W4289133744A5051787191 @default.
• W4289133744 hasAuthorship W4289133744A5055022840 @default.
• W4289133744 hasAuthorship W4289133744A5074579295 @default.
• W4289133744 hasAuthorship W4289133744A5076902141 @default.
• W4289133744 hasAuthorship W4289133744A5087530091 @default.
• W4289133744 hasBestOaLocation W42891337441 @default.
• W4289133744 hasConcept C126322002 @default.
• W4289133744 hasConcept C126894567 @default.
• W4289133744 hasConcept C141071460 @default.
• W4289133744 hasConcept C2779145901 @default.
• W4289133744 hasConcept C2779279991 @default.
• W4289133744 hasConcept C2779915274 @default.
• W4289133744 hasConcept C2779929075 @default.
• W4289133744 hasConcept C3019249673 @default.
• W4289133744 hasConcept C71924100 @default.
• W4289133744 hasConceptScore W4289133744C126322002 @default.
• W4289133744 hasConceptScore W4289133744C126894567 @default.
• W4289133744 hasConceptScore W4289133744C141071460 @default.
• W4289133744 hasConceptScore W4289133744C2779145901 @default.
• W4289133744 hasConceptScore W4289133744C2779279991 @default.
• W4289133744 hasConceptScore W4289133744C2779915274 @default.
• W4289133744 hasConceptScore W4289133744C2779929075 @default.
• W4289133744 hasConceptScore W4289133744C3019249673 @default.
• W4289133744 hasConceptScore W4289133744C71924100 @default.
• W4289133744 hasIssue "7" @default.
• W4289133744 hasLocation W42891337441 @default.
• W4289133744 hasLocation W42891337442 @default.
• W4289133744 hasLocation W42891337443 @default.
• W4289133744 hasOpenAccess W4289133744 @default.

• next